Commentary on: diagnostic accuracy and predictive value of the QuantiFERON-TB Gold Plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study

IF 13 Q1 HEALTH CARE SCIENCES & SERVICES

Lancet Regional Health-Europe Pub Date : 2025-08-29 DOI:10.1016/j.lanepe.2025.101436

Victoria Allen, James Galloway

引用次数: 0

查看原文本刊更多论文

评论：QuantiFERON-TB Gold Plus检测对免疫功能低下个体结核病的诊断准确性和预测价值：一项前瞻性TBnet研究

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lancet Regional Health-Europe Multiple-

CiteScore

19.90

自引率

1.40%

发文量

260

审稿时长

9 weeks

期刊介绍： The Lancet Regional Health – Europe, a gold open access journal, is part of The Lancet's global effort to promote healthcare quality and accessibility worldwide. It focuses on advancing clinical practice and health policy in the European region to enhance health outcomes. The journal publishes high-quality original research advocating changes in clinical practice and health policy. It also includes reviews, commentaries, and opinion pieces on regional health topics, such as infection and disease prevention, healthy aging, and reducing health disparities.